News Journey Biosciences appoints Greg Dooley & Gordie Nye to its board of directors October 28, 2021
News Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care October 14, 2021
News Introducing Journey Biosciences and NaviDKD: Preventing Diabetes-Related Kidney Complications September 30, 2021
Study Advanced Glycation End Products (AGEs); Role in Development and Progression of Kidney Disease in Type 1 Diabetes in DCCT/EDIC July 1, 2018
Study Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes December 1, 2016
Study Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products October 14, 2013
Study Detection of Diabetic Nephropathy from AGEs Differs in Plasma and Urine, and is Dependent on the Method of Preparation September 14, 2013
